 |
 |

Tomato Juice and Platelet Aggregation in Type 2 Diabetes
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Metabolic abnormalities in type 2 diabetes are associated with increased platelet sensitivity to proaggregants and decreased platelet sensitivity to endogenous antiaggregants.1-2 Thus, patients with type 2 diabetes have an increased risk of developing atherosclerosis and cardiovascular complications.2
Consumption of tomato products has been found to be inversely correlated with incidence of acute coronary events, development of early atherosclerosis, and mortality from heart disease.3 Furthermore, clarified tomato juice has been shown to inhibit human platelet aggregation in vitro4-5 and in an animal model.6 We examined whether consumption of tomato juice clarified by filtration could inhibit platelet aggregation in patients with type 2 diabetes or impaired glucose tolerance.
Methods
Patients with type 2 diabetes (n = 18) or impaired glucose tolerance (n = 2) without prior history of thromboembolic events were recruited from the community using media advertising. Fourteen men and 6 women aged 43 to 82 years with a . . . [Full Text of this Article]
Sheryl A. Lazarus, BS
Department of Nutrition and Dietetics Faculty of Health University of Newcastle
Kerry Bowen, PhD, FRACP
Diabetes Education Centre Royal Newcastle Hospital
Manohar L. Garg, PhD, APD
manohar.garg@newcastle.edu.au Department of Nutrition and Dietetics Faculty of Health University of Newcastle Newcastle, Australia
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|